The accompanying notes are an integral part of
the unaudited condensed financial statements.
The accompanying notes are an integral part of
the unaudited condensed financial statements.
The accompanying notes are an integral part of
the unaudited condensed financial statements.
The accompanying notes are an integral part of
the unaudited condensed financial statements.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS
OPERATIONS AND GOING CONCERN
Jupiter Acquisition Corporation (the “Company”)
is a blank check company incorporated in Delaware on June 17, 2020. The Company was formed for the purpose of effecting a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business
Combination”).
The Company is not limited to a particular industry
or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such,
the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of March 31, 2023, the Company had not commenced
any operations. All activity for the period from June 17, 2020 (inception) through March 31, 2023 relates to the Company’s formation
and the initial public offering (“Initial Public Offering”), which is described below, and, subsequent to the Initial Public
Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the
completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from
the proceeds derived from the marketable securities held in the Trust Account (defined below).
The registration statement for the Company’s
Initial Public Offering was declared effective on August 12, 2021. On August 17, 2021, the Company consummated the Initial Public Offering
of 15,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold,
the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $150,000,000 which is described in Note 3.
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of 580,000 units (the “Private Placement Units”) at a price of $10.00 per
Private Placement Unit in a private placement to Jupiter Founders LLC (the “Sponsor”) and certain of the underwriters and
certain of the underwriters’ employees, generating gross proceeds of $5,800,000, which is described in Note 4.
On August 23, 2021, the underwriters notified
the Company of their exercise of the over-allotment option in part and concurrent forfeiture of the remaining portion of such option.
As such, on August 25, 2021, the underwriters purchased 761,850 additional Units at $10.00 per additional Unit upon the closing of the
partial exercise of the over-allotment option, generating gross proceeds of $7,618,500. Simultaneously with the sale of the additional
Units, the Company consummated the sale of an additional 15,237 Private Placement Units at $10.00 per additional Private Placement Unit,
generating total gross proceeds of $152,370.
Transaction costs amounted to $9,292,595, consisting
of $3,152,370 of underwriting fees, net of reimbursement, $5,516,648 of deferred underwriting fees and $623,577 of other offering costs.
On March 31, 2023, Nomura Securities
International, Inc. (“Nomura”), an underwriter of the Initial Public Offering, agreed to waive its entitlement to the deferred
underwriting commissions of $4,046,657 owed or payable to Nomura pursuant to the underwriting agreement for the Initial Public
Offering (the “Underwriting Agreement”). As a result, the Company recognized $245,002 of
other income attributable to the derecognition of deferred underwriting fees allocated to offering costs and $3,801,655 was recorded
to additional paid-in capital in relation to the waiver of the deferred underwriting discount in the accompanying financial statements
(see Note 6).
On April 12, 2023, Brookline Capital Markets, a division of Arcadia
Securities, LLC (“Brookline”) and Ladenburg Thalmann & Co. Inc. (“Ladenburg”), constituting all of the underwriters
of the Initial Public Offering (other than Nomura), notified the Company pursuant to a letter dated as of April 6, 2023, that each of
Brookline and Ladenburg agreed to waive its entitlement to the cash payment of deferred underwriting commissions owed or payable pursuant
to the Underwriting Agreement and will each accept 150,000 common shares, totaling an aggregate of 300,000 common shares, of the surviving
company of the Company’s initial Business Combination in full satisfaction of the aggregate $1,469,991 that would be payable to
such underwriters upon the closing of the Company’s initial Business Combination pursuant to the Underwriting Agreement.
Following the closing of the Initial Public Offering
on August 17, 2021, an amount of $150,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering
and the sale of the Private Placement Units was placed in a trust account established for the benefit of the Company’s Public Stockholders
(as defined below) (the “Trust Account”), with Continental Stock Transfer & Trust Company acting as trustee (“Continental”),
and was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of
1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in money market funds meeting
certain conditions under Rule 2a-7 of the Investment Company Act that invest only in direct U.S. government treasury obligations,
until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account
to the Company’s stockholders, as described below.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
A total of $7,618,500 of the net proceeds from
the sale of the additional Units and the additional Private Placement Units was deposited in the Trust Account, bringing the aggregate
proceeds held in the Trust Account to $157,618,500.
In connection with the implementation of the Extension
(as defined in Note 10) on April 20, 2023, as previously approved by the Company’s stockholders on April 18, 2023, the Company redeemed
14,286,357 shares of Class A common stock tendered for redemption by the Public Stockholders, at a redemption price of approximately $10.16
per share, for an aggregate redemption amount of approximately $145.2 million (see Note 10).
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering, including the partial exercise of the over-allotment
option, and sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. The Company must complete its initial Business Combination with one or more operating businesses
with an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting
commissions and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into the initial Business
Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the
outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not
to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able
to successfully effect a Business Combination.
The Company will provide the holders of the outstanding
Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the
completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination
or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination
or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata
portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds
held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed
to the Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company may
pay to the underwriters (as discussed in Notes 6 and 10). There will be no redemption rights upon the completion of a Business Combination
with respect to the Company’s warrants.
The Company will proceed with a Business Combination
if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks
stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required
by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other
reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”),
conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file
tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is
required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business
or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not
pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and
other holders of the Company’s common stock prior to the Initial Public Offering (the “Initial Stockholders”) have agreed
to vote their Founder Shares (as defined in Note 5), Private Shares (as defined in Note 4) and any Public Shares purchased during or after
the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their
Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
Notwithstanding the above, if the Company seeks
stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate
of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such
stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15%
of the Public Shares, without the prior consent of the Company.
The Initial Stockholders have agreed (a) to
waive their redemption rights with respect to the Founder Shares, Private Shares and Public Shares held by them in connection with the
completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the
substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination
or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined
below) or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity,
unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
In connection with the implementation of the Extension,
the Company will have until December 17, 2023, or such earlier date as determined by the Company’s board of directors, to consummate
a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the
Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably
possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the
aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously
released to the Company to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding
Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive
further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the
approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in
each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable
law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless
if the Company fails to complete a Business Combination within the Combination Period.
The Initial Stockholders have agreed to waive
their right to liquidating distributions from the Trust Account with respect to the Founder Shares and Private Shares if the Company fails
to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after
the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails
to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred
underwriting commissions (see Notes 6 and 10) held in the Trust Account in the event the Company does not complete a Business Combination
within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will
be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of
the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
In order to protect the amounts held in the Trust
Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or
products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement,
reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount
per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share
due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a
third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account nor will it
apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an
executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability
for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account
due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered
public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with
the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity and Going Concern
As of March 31, 2023, the Company had $443,517
in its operating bank account and a working capital deficit of $425,030 (after adding back $50,099 in franchise tax payable as that liability,
which is included in accrued expenses in the accompanying balance sheet, is allowed to be settled using earnings from the Trust Account
and $1,202 of franchises taxes paid out of the operating cash account not yet reimbursed from the Trust Account), which excludes $3,338,005
of interest earned on the Trust Account that is available to pay franchise and income taxes payable.
As of March 31, 2023, approximately $3,339,000
of the amount on deposit in the Trust Account represented interest income, which is available to pay the Company’s tax obligations.
As of March 31, 2023, the Company withdrew an amount of $534,999 in the interest income from the Trust Account to pay tax obligations.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
Until the consummation of a Business Combination,
the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing
due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring,
negotiating and consummating the Business Combination.
The Company may need to raise additional capital
through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers,
directors and Sponsor, or their affiliates, may, but are not obligated to, loan the Company additional funds, from time to time or at
any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly,
the Company may not be able to obtain such additional financing. If the Company is unable to raise additional capital, it may be required
to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending
the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will
be available to it on commercially acceptable terms, if at all.
In connection with the Company’s assessment
of going concern considerations in accordance with Financial Accounting Standard Board’s (“FASB”) Accounting Standards
Update 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management
has determined that if the Company is unable to complete a Business Combination by December 17, 2023, then the Company will cease all
operations except for the purpose of liquidating.
In connection with the Company’s assessment
of going concern considerations in accordance with FASB Accounting Standards Codification Subtopic 205-40, “Presentation of Financial
Statements – Going Concern,” the Company has until December 17, 2023 to consummate a Business Combination or effect an extension.
It is uncertain that the Company will be able to consummate a Business Combination or effect an extension by this time. If a Business
Combination is not consummated by this date and an extension has not been approved by the Company’s stockholders and effected, there
will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and
the mandatory liquidation, should a Business Combination not occur and an extension not be approved by the Company’s stockholders
and effected, and potential subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern.
No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December
17, 2023. The Company intends to continue to search for and seek to complete a Business Combination before the mandatory liquidation date.
Risks and Uncertainties
Management continues to evaluate the impact of
the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s
financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as
of the date of the condensed financial statements. The condensed financial statements do not include any adjustments that might result
from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus
commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have
instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on
the world economy are not determinable as of the date of these condensed financial statements and the specific impact on the Company’s
financial condition, results of operations, and cash flows is also not determinable as of the date of these condensed financial statements.
The funds in the Trust Account are invested only
in U.S. government treasury bills with a maturity of 185 days or less or in money market funds that meet certain conditions under Rule
2a-7 under the Investment Company Act and that invest only in direct U.S. government obligations. While short-term U.S. government treasury
bills currently yield a positive rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in
Europe and Japan pursued interest rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled
out the possibility that it may in the future adopt similar policies in the United States. In the event that the Company is unable to
complete its initial Business Combination or makes certain amendments to the Certificate of Incorporation, the Public Stockholders are
entitled to receive their pro-rata share of the proceeds held in the Trust Account, plus any interest income not released to the Company,
net of taxes payable. Negative interest rates could impact the per share redemption amount that may be received by Public Stockholders.
Consideration of Inflation Reduction Act
Excise Tax
On August 16, 2022, the Inflation Reduction Act
of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise
tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded
foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its
shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased
at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the
fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition,
certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority
to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
Any redemption or other repurchase that occurs
after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether
and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise
would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business
Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE”
or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination
but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury.
In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment
of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business
Combination and in the Company’s ability to complete a Business Combination.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S.
GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of
the SEC. Certain information or footnote disclosures normally included in condensed financial statements prepared in accordance with U.S.
GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they
do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or
cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting
of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows
for the periods presented.
The accompanying unaudited condensed financial
statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as
filed with the SEC on March 10, 2023. The interim results for the three months ended March 31, 2023 are not necessarily indicative of
the results to be expected for the period ending December 31, 2023 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that
when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company’s condensed financial statements with another public company which is neither an emerging growth company nor an emerging
growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences
in accounting standards used.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
Use of Estimates
The preparation of the condensed financial statements
in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the
reported amounts of expenses during the reporting periods.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change
in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed
financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more
current information becomes available and, accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2023 and December 31, 2022, the
Company has cash of $443,517 and $324,188, respectively. The Company did not have any cash equivalents at March 31, 2023 and December
31, 2022.
Marketable Securities Held in Trust Account
At March 31, 2023 and December 31, 2022, substantially
all of the assets held in the Trust Account were held in U.S. Treasury securities. Through March 31, 2023, the Company withdrew an amount
of $534,999 in the interest income from the Trust Account to pay tax obligations.
Offering Costs
Offering costs consist of underwriting, legal,
accounting and other expenses incurred through the condensed balance sheet date that are directly related to the Initial Public Offering.
Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value
basis, compared to total proceeds received. Offering costs allocated to derivative warrant liabilities are expensed as incurred in the
statements of operations. Offering costs associated with the Class A common stock issued were initially charged to temporary equity and
then accreted to common stock subject to redemption upon the completion of the Initial Public Offering. Offering costs amounted to $9,292,595,
of which $8,938,077 were charged to stockholders’ equity upon the completion of the Initial Public Offering and $354,518 were expensed
to the statements of operations.
Warrant Liabilities
The Company accounts for the Public Warrants (as
defined in Note 3) and the Private Warrants (as defined in Note 4) (collectively, with the Public Warrants, the “Warrants”)
in accordance with the guidance contained in FASB Accounting Standards Codification (“ASC”) Topic 480 and FASB ASC Topic 815
“Derivatives and Hedging” (“ASC 815”) under which the Warrants do not meet the criteria for equity treatment and
must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants
to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any
change in fair value is recognized in the statements of operations. On August 17, 2021 and subsequently on September 30, 2021, the Public
Warrants were valued using a Monte Carlo Simulation model. The Private Warrants were valued using a Black Scholes model at December 31,
2021. For periods subsequent to the detachment of the Public Warrants from the Units including March 31, 2023, the close price of the
Public Warrant price was used as the fair value as of each relevant date. In addition, as of March 31, 2023, the closing price of the
Public Warrants was determined to be an appropriate estimate for the fair value of Private Warrants due to a make-whole provision in the
contractual terms of the Warrant Agreement.
Income Taxes
The Company follows the asset and liability method
of accounting for income taxes under ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for
the estimated future tax consequences attributable to differences between the financial statement’s carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
ASC Topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in
a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing
authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were
no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2023 and 2022. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The
Company is subject to income tax examinations by major taxing authorities since inception.
Class A Common Stock Subject to Possible
Redemption
The Company accounts for its Class A common stock
subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.”
Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value.
Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the
holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as
temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock
features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain
future events. Accordingly, at March 31, 2023 and December 31, 2022, 15,761,850 shares of Class A common stock subject to possible redemption
are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed
balance sheets.
The Company recognizes changes in redemption value
immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting
period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption
amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital
and accumulated deficit.
At March 31, 2023 and December 31, 2022, the Class
A common stock reflected in the condensed balance sheets is reconciled in the following table:
Gross proceeds | |
$ | 157,618,500 | |
Less: | |
| | |
Proceeds allocated to Public Warrants | |
| (6,018,995 | ) |
Class A common stock issuance costs | |
| (8,768,627 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 16,102,462 | |
| |
| | |
Class A common stock subject to possible redemption 12/31/22 | |
| 158,933,340 | |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 1,239,625 | |
| |
| | |
Class A common stock subject to possible redemption 03/31/23 | |
$ | 160,172,965 | |
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
Net Income per Common Share
The Company complies with accounting and disclosure
requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per common share is computed by dividing net income by
the weighted average number of shares of common stock outstanding for the period. Accretion associated with the redeemable shares of Class
A common stock is excluded from net income per common share as the redemption value approximates fair value.
The calculation of diluted income per share does
not consider the effect of the Warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement
since the exercise of the Warrants is contingent upon the occurrence of future events. The Warrants are exercisable to purchase 8,178,543 shares
of Class A common stock in the aggregate. As of March 31, 2023 and 2022, the Company did not have any dilutive securities or other
contracts that could, potentially, be exercised or converted into common shares and then share in the net income of the Company. As a
result, diluted net income per common share is the same as basic net income per common share for the periods presented.
The following table reflects the calculation of
basic and diluted net income per common share (in dollars, except per share amounts):
| |
For the Three Months Ended March 31, | |
| |
2023 | | |
2022 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic and diluted net income per common stock | |
| | | |
| | | |
| | | |
| | |
Numerator: | |
| | | |
| | | |
| | | |
| | |
Allocation of net income, as adjusted | |
$ | 570,387 | | |
$ | 137,407 | | |
$ | 629,925 | | |
$ | 151,750 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average common stock outstanding | |
| 16,357,087 | | |
| 3,940,462 | | |
| 16,357,087 | | |
| 3,940,462 | |
Basic and diluted net income per common stock | |
$ | 0.03 | | |
$ | 0.03 | | |
$ | 0.04 | | |
$ | 0.04 | |
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal
Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts.
Fair Value of Financial Instruments
The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying
amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for warrant liabilities (see Note
9).
Recent Accounting Standards
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed
financial statements.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company
sold 15,761,850 Units at a purchase price of $10.00 per Unit, including 761,850 additional Units pursuant to the underwriters’ partial
exercise of their over-allotment option. Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant
(“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at an
exercise price of $11.50, subject to adjustment (see Note 8).
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial
Public Offering and the closing of the partial exercise of the over-allotment option, the Sponsor and certain of the underwriters and
certain of the underwriters’ employees purchased an aggregate of 595,237 Private Placement Units at a price of $10.00 per Private
Placement Unit for an aggregate purchase price of $5,952,370 in private placements. Each Private Placement Unit consists of one share
of Class A common stock (“Private Share”) and one-half of one warrant (each, a “Private Warrant”). Each whole
Private Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment.
A portion of the proceeds from the Private Placement Units were added to the proceeds from the Initial Public Offering held in the Trust
Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private
Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private
Placement Units and all underlying securities will expire worthless. There will be no redemption rights or liquidating distributions from
the Trust Account with respect to the Private Placement Units or the underlying securities.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On July 7, 2020, the Initial Stockholders purchased
5,750,000 shares of the Company’s Class B common stock (the “Founder Shares”) for an aggregate price of $25,000. On
July 23, 2021, the Sponsor forfeited 1,437,500 Founder Shares resulting in an aggregate of 4,312,500 Founder Shares outstanding. The Sponsor
agreed to transfer to certain of the underwriters and certain of their employees an aggregate of 240,001 shares of Class B common stock.
All shares and per-share data has been retroactively restated. The Founder Shares included an aggregate of up to 562,500 Founder Shares
that were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part.
On August 23, 2021, the underwriters notified the Company of their exercise of the over-allotment option in part and concurrent forfeiture
of the remaining portion of such option. As such, on August 25, 2021, the underwriters purchased 761,850 additional Units at $10.00 per
additional Unit upon the closing of the partial exercise of the over-allotment option. As a result of the underwriters’ election
to partially exercise their over-allotment option and the forfeiture of the remaining portion of such over-allotment option, an aggregate
of 372,038 Founder Shares were forfeited and 190,462 Founder Shares are no longer subject to forfeiture, resulting in an aggregate of
3,940,462 Founder Shares outstanding at August 25, 2021.
The Initial Stockholders have agreed, subject
to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after
the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of
the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination,
or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results
in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
Of the aggregate 15,761,850 Units sold in the
Initial Public Offering, 13,365,000 Units were purchased by certain qualified institutional buyers or institutional accredited investors
that are not affiliated with the Company, the Sponsor, the Company’s directors or any member of the Company’s management team
(the “Anchor Investors”).
In connection with the closing of the Initial
Public Offering, the Anchor Investors each acquired from the Sponsor an indirect economic interest in 100,000 Founder Shares (or an aggregate
of 900,000 Founder Shares) at the original purchase price that the Sponsor paid for the Founder Shares. The Sponsor has agreed to distribute
such Founder Shares to the Anchor Investors after the completion of a Business Combination. The Company estimated the aggregate fair value
of the Founder Shares attributable to the Anchor Investors to be $4,464,000, or $4.96 per share. The fair value of the Founder Shares
were valued using a binomial/lattice model. The excess of the fair value of the Founder Shares was determined to be an offering cost in
accordance with Staff Accounting Bulletin Topic 5A. Accordingly, the offering cost was allocated to the separable financial instruments
issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs related
to the Founder Shares amounted to $4,464,000, of which $170,341 were expensed in the statements of operations and included in transactions
costs attributable to warrant liabilities and the remaining $4,296,659 netted to additional paid in capital resulting in only a charge
to accumulated deficit of $170,341.
On April 20, 2023, pursuant to the Class B Conversion
(as defined in Note 10), the Founder Shares were converted from shares of Class B common stock to shares of Class A common stock on a
one-for-one basis in accordance with the Certificate of Incorporation (see Note 10).
Administrative Services Agreement
The Company entered into an agreement on August
12, 2021, through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of
the Sponsor an aggregate of $15,000 per month for office space, utilities and secretarial and administrative support. For the three months
ended March 31, 2023, the Company incurred and paid $45,000 in fees for these services. For the three months ended March 30, 2022, the
Company incurred $45,000 in fees for these services, of which such amount is included in accrued expenses in the accompanying condensed
balance sheets.
Promissory Note — Related Party
On June 24, 2020, the Company issued an unsecured
promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal
amount of $250,000. The Promissory Note was subsequently amended on December 31, 2021 and 2020 to extend the maturity date. The Promissory
Note was non-interest bearing and payable on the earlier of (i) December 31, 2021 and (ii) the consummation of the Initial Public Offering.
As of March 31, 2023 and December 31, 2022, there were no amounts outstanding under the Promissory Note. The outstanding balance under
the Note was repaid at the closing of the Initial Public Offering on August 17, 2021, and the Promissory Note was terminated.
Related Party Loans
In order to finance transaction costs in connection
with a Business Combination, the Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but
are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business
Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise,
the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does
not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital
Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either
be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such
Working Capital Loans may be converted into units at a price of $10.00 per unit at the option of the lender. The units would be identical
to the Private Placement Units. As of March 31, 2023 and December 31, 2022, there were no Working Capital Loans outstanding.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
NOTE 6. COMMITMENTS
Registration Rights
Pursuant to a registration rights agreement entered
into on August 12, 2021, the holders of the Founder Shares, Private Placement Units, Private Shares, Private Warrants, and units that
may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the
Private Warrants and warrants included in the units that may be issued upon conversion of Working Capital Loans and upon conversion of
the Founder Shares) will be entitled to registration rights requiring the Company to register such securities for resale (in the case
of the Founder Shares, only after conversion to the Company’s Class A common stock). The holders of the majority of these securities
are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders
have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of
a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities
Act. Notwithstanding the foregoing, the underwriters may not exercise their demand and “piggy-back” registration rights after
August 12, 2026 and August 12, 2028, respectively, and may not exercise their demand rights on more than one occasion. The Company will
bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters a 45-day
option beginning August 12, 2021 to purchase up to 2,250,000 additional Units to cover over-allotments, at the Initial Public Offering
price less the underwriting discounts and commissions. On August 23, 2021, the underwriters notified the Company of their exercise of
the over-allotment option in part and concurrent forfeiture of the remaining portion of such option. As such, on August 25, 2021, the
underwriters purchased 761,850 additional Units upon the closing of the partial exercise of the over-allotment option.
The underwriters were entitled to a deferred fee
of $0.35 per Unit, or $5,516,648 in the aggregate, pursuant to the terms of the Underwriting Agreement, which deferred fee would (i) become
payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination
and (ii) be waived by the underwriters in the event that the Company does not complete a Business Combination.
On March 31, 2023, Nomura agreed
to waive its entitlement to the deferred underwriting commissions of $4,046,657 owed or payable to Nomura in accordance with the Underwriting
Agreement. As a result, the Company recognized $245,002 of other income attributable to the derecognition of deferred underwriting
fees allocated to offering costs and $3,801,655 was recorded to additional paid-in capital in relation to the waiver of the deferred
underwriting discount in the accompanying financial statements.
Financing Arrangement
Nomura has indicated its intent, if so requested
by the Company, to use its commercially reasonable efforts to underwrite, arrange and/or syndicate up to $400 million of additional financing
for the Company in the form of equity or debt (or a combination thereof) in connection with the Company’s initial Business Combination,
subject to market conditions and on terms and conditions satisfactory in all respects to Nomura in its sole judgment and determination.
The additional financing arrangement is not anticipated to have any impact on the redemption price of the Class A common stock, the conversion
ratio of Class B common stock to Class A common stock or the exercise of the Warrants.
Legal Services Agreement
Services rendered by the Company’s legal counsel are accrued
on an ongoing basis but deferred for settlement until the closing of an initial Business Combination. The accrued fees were $1,043,069
and $758,955 as of March 31, 2023 and December 31, 2022, respectively.
NOTE 7. STOCKHOLDERS’ DEFICIT
Preferred Stock — The
Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting
and other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2023 and
December 31, 2022, there were no shares of preferred stock issued and outstanding.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
Class A Common Stock —
The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A
common stock are entitled to one vote for each share. At March 31, 2023 and December 31, 2022, there were 595,237 shares of Class A common
stock issued and outstanding, excluding 15,761,850 shares of Class A common stock subject to possible redemption which are presented as
temporary equity.
Class B Common Stock —
The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B
common stock are entitled to one vote for each share. At March 31, 2023 and December 31, 2022, there were 3,940,462
shares of Class B common stock issued and outstanding. At December 31, 2020, there were 4,312,500
shares of Class B common stock issued and outstanding, of which an aggregate of up to 562,500 shares of Class B common stock were
subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the
number of shares of Class B common stock would equal 20% of the Company’s issued and outstanding common stock after the Initial
Public Offering (not including the Private Shares underlying the Private Placement Units). As a result of the underwriters’
election to partially exercise their over-allotment option and the forfeiture of the remaining portion of such over-allotment option,
372,038 Founder Shares were forfeited and 190,462 Founder Shares are no longer subject to forfeiture, resulting in an aggregate of 3,940,462
Founder Shares outstanding at August 25, 2021.
Only holders of Class B common stock have the
right to vote on the election of directors prior to the Company’s initial Business Combination. Holders of Class A common stock
and holders of Class B common stock will vote together as a single class on all other matters submitted to a vote of the Company’s
stockholders except as otherwise required by law.
The shares of Class B common stock will automatically
convert into shares of Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one
basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed
issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio
at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority
of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance)
so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the
aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon completion of the
Initial Public Offering (not including the Private Shares underlying the Private Placement Units) plus all shares of Class A common stock
and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked
securities issued, or to be issued, to any seller in a Business Combination and any private placement-equivalent warrants issued to the
Sponsor or its affiliates upon conversion of loans made to the Company).
On April 20, 2023, pursuant to the Class B Conversion
(as defined in Note 10), the Founder Shares were converted from shares of Class B common stock to shares of Class A common stock on a
one-for-one basis in accordance with the Certificate of Incorporation (see Note 10).
NOTE 8. WARRANT LIABILITIES
At March 31, 2023 and December 31, 2022, there
were 7,880,925 Public Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional warrants
will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable 30 days after
the completion of a Business Combination. The Public Warrants will expire five years after the completion of a Business Combination or
earlier upon redemption or liquidation.
The Company will not be obligated to deliver any
shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless
a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective
and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant
will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless the
shares of Class A common stock issuable upon such warrant exercise have been registered, qualified or deemed to be exempt under the securities
laws of the state of residence of the registered holder of the warrants.
The Company has agreed that as soon as practicable,
but in no event later than 15 business days after the closing of a Business Combination, the Company will use its commercially reasonable
efforts to file with the SEC a registration statement for the registration under the Securities Act of the shares of Class A common stock
issuable upon exercise of the warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective
within 60 business days following a Business Combination and to maintain a current prospectus relating to the Class A common stock issuable
upon exercise of the warrants, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration
statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business
day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement
and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless
basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
Redemption of warrants when the price per share
of Class A common stock equals or exceeds $18.00. Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:
|
● |
in whole and not in part; |
| ● | at a price of $0.01 per warrant; |
| ● | upon
not less than 30 days’ prior written notice of redemption to each warrant holder; and |
| ● | if, and only if, the last reported sale price of the shares of Class A common stock for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities). |
If and when the warrants become redeemable by
the Company, the Company may not exercise its redemption right if the issuance of shares of common stock upon exercise of the warrants
is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration
or qualification, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration.
Redemption of warrants when the price per share
of Class A common stock equals or exceeds $10.00. Once the Public Warrants become exercisable, the Company
may redeem the Public Warrants:
|
● |
in whole and not in part; |
| ● | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table in the prospectus for the Initial Public Offering, based on the redemption date and the fair market value of the Class A common stock; |
| ● | if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities); and |
| ● | if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) the Private Warrants must also be concurrently called for redemption on the same terms (except as described above with respect to a holder’s ability to cashless exercise its warrants) as the outstanding Public Warrants |
If the Company calls the Public Warrants for redemption,
management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,”
as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants
may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation.
However, the warrants will not be adjusted for issuance of Class A common stock at a price below the exercise price. Additionally, in
no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within
the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such
funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust
Account with respect to such warrants. Accordingly, the warrants may expire worthless.
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
In addition, if (x) the Company issues additional
shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial
Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue
price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance
to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable,
prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than
60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation
of its initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class
A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial
Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be
adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00
per share redemption trigger prices will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value
and the Newly Issued Price, respectively.
As of March 31, 2023 and December 31, 2022, there
were 297,618 Private Warrants outstanding. The Private Warrants are identical to the Public Warrants underlying the Units sold in the
Initial Public Offering, except that the Private Warrants and the shares of Class A common stock issuable upon the exercise of the Private
Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain
limited exceptions, and the holders thereof are entitled to certain registration rights. Additionally, so long as they are held by the
initial purchasers or their permitted transferees, the Private Warrants: (i) will not be redeemable by the Company (except for certain
limitations); (ii) may be exercised by the holders on a cashless basis; and (iii) with respect to Private Warrants held by the underwriters
or their employees, will not be exercisable more than five years from the commencement of sales of the Initial Public Offering in accordance
with FINRA Rule 5110(g)(8)(A). If the Private Warrants are held by holders other than the initial purchasers or their respective permitted
transferees, the Private Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the
same basis as the Public Warrants.
NOTE 9. FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
|
Level 1: |
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
|
Level 2: |
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
|
Level 3: |
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
The following table presents information about
the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2023 and December 31, 2022,
and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
Description | |
Level | |
March 31, 2023 | | |
December 31, 2022 | |
Assets: | |
| |
| | |
| |
Marketable securities held in Trust Account | |
1 | |
$ | 160,956,505 | | |
$ | 159,610,253 | |
| |
| |
| | | |
| | |
Liabilities: | |
| |
| | | |
| | |
Warrant liability- Public Warrants | |
1 | |
$ | 709,283 | | |
$ | 472,856 | |
Warrant liability- Private Warrants | |
2 | |
$ | 26,785 | | |
$ | 17,857 | |
JUPITER ACQUISITION CORPORATION
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2023
(UNAUDITED)
The Warrants were accounted for as liabilities
in accordance with ASC Topic 815-40 and are presented within warrant liabilities in the accompanying condensed March 31, 2023 and December
31, 2022 balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair
value presented within the condensed statements of operations.
On August 17, 2021, the “Public Warrants”
were valued using a Monte Carlo Simulation model, which is considered to be a Level 3 fair value measurement. On August 17, 2021 and on
December 31, 2021, the Private Warrants were valued using a Black Scholes model, considered a level 3 fair value measurement. The primary
unobservable input utilized in determining the fair value of the Warrants is the expected volatility of the common stock. The expected
volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’
companies without an identified target. On December 31, subsequent to the detachment of the Public Warrants from the Units, the close
price of the Public Warrant price was used as the fair value of the Public Warrants. For periods subsequent to the detachment of the Public
Warrants from the Units including March 31, 2023, the close price of the Public Warrant price was used as the fair value as of each relevant
date. In addition, as of March 31, 2023, Private Warrants transferred to Level 2 due to a make-whole provision which allows the Company
to use the value of the closing price of the Public Warrants. There was no transfer as of March 31, 2023.
The following table presents the changes in the
fair value of Level 3 warrant liabilities:
| |
Private Placement | | |
Public | | |
Warrant Liabilities | |
Fair value as of December 31, 2021 | |
$ | 144,910 | | |
$ | — | | |
$ | 144,910 | |
Change in valuation inputs or other assumptions | |
| (46,696 | ) | |
| — | | |
| (46,696 | ) |
Transfer to level 2 | |
| (98,214 | ) | |
| — | | |
| (98,214 | ) |
Fair value as of March 31, 2022 | |
$ | — | | |
$ | — | | |
$ | — | |
Transfers to/from Levels 1, 2 and 3 are recognized
at the end of the reporting period in which a change in valuation technique or methodology occurs. The estimated fair value of the Private
Warrants that were transferred from a Level 3 measurement to a Level 2 at March 31, 2022.
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions
that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review,
other than described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the
condensed financial statements.
On April 12, 2023, Brookline and Ladenburg, constituting all of the
underwriters of the Initial Public Offering (other than Nomura), notified the Company pursuant to a letter dated as of April 6, 2023,
that each of Brookline and Ladenburg agreed to waive its entitlement to the cash payment of deferred underwriting commissions owed or
payable pursuant to the Underwriting Agreement and will each accept 150,000 common shares, totaling an aggregate of 300,000 common shares,
of the surviving company of the Company’s initial Business Combination in full satisfaction of the aggregate $1,469,991 that would
be payable to such underwriters upon the closing of the Company’s initial Business Combination pursuant to the Underwriting Agreement.
On April 18, 2023, the Company held a special
meeting in lieu of the 2023 annual meeting of stockholders of the Company (the “Special Meeting”). At the Special Meeting,
the Company’s stockholders approved, among other matters, (i) an amendment to the Certificate of Incorporation to extend the date
by which the Company must consummate an initial Business Combination (the “Extension”) from August 17, 2023 to December 17,
2023, or such earlier date as determined by the Company’s board of directors (such applicable date, the “Extended Date”,
and such amendment, the “Charter Amendment”), and (ii) an amendment to the Investment Management Trust Agreement, dated as
of August 12, 2021, by and between the Company and Continental, to provide for the Extension to the Extended Date pursuant to the Charter
Amendment (the “Trust Amendment”).
Following the Special Meeting, on April 20, 2023,
the Company filed the Charter Amendment with the Secretary of State of the State of Delaware in order to implement the Extension and entered
into the Trust Amendment with Continental.
In connection with the implementation of the Extension,
(i) on April 20, 2023, all holders of Class B common stock voluntarily elected to convert all shares of Class B common stock to shares
of Class A common stock on a one-for-one basis in accordance with the Certificate of Incorporation (collectively, the “Class B Conversion”),
and (ii) the Company redeemed 14,286,357 shares of Class A common stock tendered for redemption by the Public Stockholders, at a redemption
price of approximately $10.16 per share, for an aggregate redemption amount of approximately $145.2 million (the “Redemption”).
Upon completion of the Class B Conversion and the Redemption, 6,011,192 shares of Class A common stock and no shares of Class B common
stock remain issued and outstanding.